Cargando…
2213 Tumor suppressors p53 and ARF control oncogenic potential of triple-negative breast cancer cells by regulating RNA editing enzyme ADAR1
OBJECTIVES/SPECIFIC AIMS: Triple-negative breast cancer (TNBC) accounts for one-fifth of the breast cancer patient population. The heterogeneous nature of TNBC and lack of options for targeted therapy make its treatment a constant adventure. The deficiency of tumor suppressors p53 and ARF is one of...
Autores principales: | Kung, Che-Pei, Bross, Emily A., Kuzmicki, Catherine E., Benjamin, Michael, Maggi, Leonard B., Weber, Jason D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799729/ http://dx.doi.org/10.1017/cts.2018.143 |
Ejemplares similares
-
3174 Tumor suppressors p53 and ARF control oncogenic potential of triple-negative breast cancer cells by regulating RNA editing enzyme ADAR1
por: Kung, Che-Pei, et al.
Publicado: (2019) -
2261 Tumor suppressor RARRES1 regulates cell survival by modulating mitochondrial energetics
por: Maimouni, Sara, et al.
Publicado: (2018) -
2456 Cutaneous lupus erythematosus patients have increased circulating myeloid-derived suppressor cells with immunosuppressive properties
por: Florez-Pollack, Stephanie, et al.
Publicado: (2018) -
2165 Vesicular secretion of suppressor of cytokine signaling 3 by alveolar macrophages is dysregulated in NSCLC patients and its provision inhibits epithelial cell transformation and tumor cell function
por: Speth, Jennifer, et al.
Publicado: (2018) -
2325 Targeting isoform-specific PI3 kinase signaling for treatment of cutaneous T cell lymphoma
por: Raychaudhuri, Suravi, et al.
Publicado: (2018)